Award-winning University of Strathclyde spinout company, Microplate Dx Limited has recently won Best 'StartUp' Business at Barclays Entrepreneur Awards 2023.

Microplate Dx is a diagnostics company that specialises in developing novel solutions to tackle the major global health threat of antimicrobial resistance. 

Dr Poonam Malik. Chair of the Board at Microplate Dx, said: 

"What a fab outcome! Microplate Dx Limited was successful in receiving the Best ‘StartUp’ Business winner's trophy from amongst the many 100s of entries submitted, shortlisted, through Regional nations rounds and then winning the National Finals in London, this time at the Barclays EntrepreneurAwards 2023, BarclaysEA23. 

Fabulous work by the whole amazing Microplate Dx Team. Commercialisation and growth journey continues in getting national recognition amongst high-potential, innovative, revenue generating growth businesses. As a MedTech, Health Technology business- this reward and recognition at the UK-wide level becomes even more positive because it is competed against all technology companies, at a sector-agnostic level. Chosen by the judges for company’s strengths in Team's Leadership, raising Investment, commercial traction, partnerships, innovation & technology uniqueness along with the business's vision and mission for longer term inclusive influence and impact on the global society."

Dr Poonam Malik continued:

"Thank you to the like-minded #Investors for their keen interest in company’s ambition and growth journey, its vision and mission: Deepbridge Capital , the University of Strathclyde, Scottish Enterprise, SIS Ventures and international backers from the USA market, Mark Bamforth ThairmBio Investment."